The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro (tirzepatide), both produced by Eli Lilly And Co. LLY, is false or misleading.The agency's review found that the video misbrands the drugs by underplaying serious health risks and omitting critical safety information.LLY shares are advancing steadily. Check the analyst’s take here.The video, a 42-minute program hosted by Oprah Winfrey, focused on weight-loss treatments and their growing popula ...